Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, September 1999, p. 2320-2322, Vol. 43, No. 9
Servicio de Microbiología
Clínica, Hospital Clínico San Carlos, 28040 Madrid,
Spain
Received 11 March 1999/Returned for modification 13 May
1999/Accepted 29 June 1999
The antimicrobial activities of trovafloxacin, moxifloxacin,
sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were
determined. A group of 10 imipenem-resistant strains were also tested.
Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Activities of New Antimicrobial Agents (Trovafloxacin,
Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) against
Bacteroides fragilis Group: Comparison with the Activities
of 14 Other Agents
-lactams. Quinupristin-dalfopristin inhibited all of the strains at
2 µg/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90%
of the strains tested were 1 and 2 µg/ml, respectively.
*
Corresponding author. Mailing address: Servicio de
Microbiología Clínica, Hospital Clínico San
Carlos, Plaza Cristo Rey s/n, 28040 Madrid, Spain. Phone: 341 3303486. Fax: 341 3303478. E-mail: cbetriu{at}efd.net.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |